Immunotherapy and Immune Responses

Dendritic cells are the immune system's primary messengers, capturing foreign or abnormal proteins and presenting them to T cells in a form that triggers a targeted response — a process called antigen presentation that sits at the center of both natural immunity and engineered therapies. Understanding how different subsets of dendritic cells recognize tumor antigens, cross-present them to cytotoxic T cells, and distinguish threats from harmless tissue is essential for designing cancer immunotherapies that reliably activate the immune system rather than leaving it tolerant or suppressed. Vaccine adjuvants, which amplify and shape these dendritic cell signals, offer one active route toward stronger and more durable responses, though researchers are still working out which adjuvant combinations produce the right kind of T cell immunity for a given cancer type. A central open question is how tumors subvert antigen presentation to evade detection, and whether restoring or redirecting dendritic cell function can overcome that suppression at scale.

Works

137,246

Total citations

3,820,278

Keywords

Dendritic CellsImmunityCancer ImmunotherapyAntigen PresentationTumor AntigenVaccine Adjuvants